PharmiWeb5h
Biotechnology Market Size, Share, Trends Research Report 2025-2034
Biotechnology Market OverviewThe Biotechnology Market report delivers crucial insights into the market's growth trajectory ...
BD (Becton, Dickinson and Company): BD Reports First Quarter Fiscal 2025 Financial Results
Company Delivers Revenue, Margin and Earnings Ahead of its Expectations Revenue of $5.2 billion increased 9.8% as reported, 9.6% currency-neutral and 3.9% organic ...
Trends Shaping The Cosmetic Antioxidants Industry, 2025-2030: Nutricosmetics And Edible Beauty Products Set The Stage For Growth
Global Revenues Projected to Exceed $180 Million by 2030, at a CAGR of 5%Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The Cosmetic Antioxidan ...
Peptide Synthesis Market to Hit USD 1.41 Billion by 2029 with 11.7% CAGR | MarketsandMarkets.
The Peptide Synthesis market valued at US$ 0.78 Billion in 2023, is forecasted to grow at a robust CAGR of 11.7%, reaching US$ 0.81 Billion in ...
FiercePharma5d
Moderna picks Merck KGaA, Roivant alum as marketing chief
As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...
Merck Is Suffering From a Classic Pharma Problem
Investors have taken to punishing pharma companies that appear unable to gauge demand for their top products. Consider Pfizer. The company’s inability to accurately project demand for its Covid-19 ...
Merck Shares Hit After Guidance Falls Short, Gardasil Challenge
The drugmaker’s guidance was affected by a pause in shipments of its top-selling vaccine to China from February through at ...
STAT5d
Merck’s earnings miss focused attention on Gardasil. The real issue is Keytruda
Merck on Tuesday missed earnings estimates, lowered its guidance for this year’s earnings, and withdrew a target for sales of ...
Merck shares plunge as company pauses Gardasil vaccine shipments in China, hurting 2025 outlook
Merck's full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...
Merck Earnings: Gardasil Weighs on 2025 Growth, but Firm Still Undervalued
Merck’s MRK fourth-quarter revenue grew 7% to $15.6 billion (including Keytruda growth of 21% to $7.8 billion), in line with ...
Le Lézard10d
Continuous Thermal Monitoring Market worth $1.49 billion by 2030 | MarketsandMarketstm
The global Continuous Thermal Monitoring Market is anticipated to grow from estimated USD 1.00 billion in 2024 to USD 1.49 billion by 2030, at a CAGR of 6.8% during the forecast period. The market is ...